Skip to content
MedsAcross

Brand family

Uzedy

Risperidone · Teva Pharmaceuticals
United States
Presentations
7
Markets
1

Uzedy is a brand of Risperidone marketed by Teva Pharmaceuticals, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Risperidone
Brand owner
Teva Pharmaceuticals
Registered in
United States
Strengths and forms
100 mg/0.28 mL extended-release injectable suspension, 125 mg/0.35 mL extended-release injectable suspension, 150 mg/0.42 mL extended-release injectable suspension, 200 mg/0.56 mL extended-release injectable suspension, 250 mg/0.7 mL extended-release injectable suspension, 50 mg/0.14 mL extended-release injectable suspension, 75 mg/0.21 mL extended-release injectable suspension

All presentations

MedicineManufacturerRegisterAvailability
Uzedy 100 mg/0.28 mL extended-release injectable suspensionSubcutaneous Cold chainTeva PharmaceuticalsUS FDAAvailable on request
Uzedy 125 mg/0.35 mL extended-release injectable suspensionSubcutaneous Cold chainTeva PharmaceuticalsUS FDAAvailable on request
Uzedy 150 mg/0.42 mL extended-release injectable suspensionSubcutaneous Cold chainTeva PharmaceuticalsUS FDAAvailable on request
Uzedy 200 mg/0.56 mL extended-release injectable suspensionSubcutaneous Cold chainTeva PharmaceuticalsUS FDAAvailable on request
Uzedy 250 mg/0.7 mL extended-release injectable suspensionSubcutaneous Cold chainTeva PharmaceuticalsUS FDAAvailable on request
Uzedy 50 mg/0.14 mL extended-release injectable suspensionSubcutaneous Cold chainTeva PharmaceuticalsUS FDAAvailable on request
Uzedy 75 mg/0.21 mL extended-release injectable suspensionSubcutaneous Cold chainTeva PharmaceuticalsUS FDAAvailable on request

Equivalent brands

Other brands of Risperidone.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Uzedy

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.